Decongestion in acute heart failure

Area of Science:

• Cardiology
• Pharmacology
• Nephrology

Background:

• Acute heart failure (HF) frequently leads to hospitalizations due to fluid congestion.
• Effective decongestion is crucial for managing acute HF patients.

Purpose of the Study:

• To review current and novel decongestion strategies for acute heart failure.
• To provide evidence-based guidance on selecting appropriate decongestion approaches for individual patients.

Main Methods:

• Review of therapeutic strategies including diuretics, vasodilators, ultrafiltration, vasopressin antagonists, and mineralocorticoid receptor antagonists.
• Discussion of benefit-risk profiles for each decongestion strategy.
• Guidance on selecting strategies based on patient characteristics and response.

Main Results:

• An initial approach involves high-dose intravenous diuretics, potentially with vasodilators.
• Dual nephron blockade (thiazides) or mineralocorticoid receptor antagonists can enhance diuresis.
• Vasopressin antagonists may aid aquaresis; ultrafiltration is an option if diuretics fail, used cautiously with renal impairment.

Conclusions:

• Selecting the optimal decongestion strategy requires careful consideration of individual patient factors.
• Evidence-based guidelines can help tailor therapy for acute heart failure congestion.
• Further research into novel therapies may expand treatment options.